Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397059 | 1.00 | CA2 (0.41) | CA2CYP3A4TSHR | |
| SCHEMBL28408357 | 1.00 | CA2 (0.41) | CA2CYP3A4TSHR | |
| SCHEMBL5243057 | 1.00 | CA2 (0.41) | CA2CYP3A4TSHR | |
| SCHEMBL687625 | 1.00 | CA2 (0.41) | CA2CYP3A4TSHR | |
| SCHEMBL224425 | 1.00 | — | — | |
| SCHEMBL5240827 | 1.00 | CA2 (0.41) | CA2CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL28135038 | 0.94 | CA2 (0.39) | CA2CYP3A4TSHR | |
| SCHEMBL23647292 | 0.83 | CA2 (0.44) | CA2CYP3A4TSHR | |
| SCHEMBL14920 | 0.83 | CA2 (0.44) | CA2CYP3A4TSHR | |
| SCHEMBL4607864 | 0.83 | CA2 (0.44) | CA2CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101393128-A | Application of fluorescent probe for detecting enzyme activity and screening passivating agent | CHINESE ACAD INST CHEMISTRY (CN) | 2009-03-25 | — | — | CN | claimed |
| CN-118176231-A | Curable resin composition | 纳美仕有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-112839922-B | Hydrophilic and in particular water-soluble DBOV derivatives | 马克斯·普朗克索赔科学公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3921320-B1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEIGENE LTD (KY) | 2024-03-06 | — | — | EP | disclosed |
| EP-3921319-B1 | IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEIGENE LTD (KY) | 2024-03-06 | — | — | EP | disclosed |
| US-20230167117-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEONE MEDICINES I GMBH (CH) | 2023-06-01 | — | — | US | disclosed |
| EP-4008720-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVE USED AS TLR8 AGONIST | BeiGene, Ltd. (KY) | 2022-06-08 | — | — | EP | disclosed |
| US-20220119394-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | BEONE MEDICINES I GMBH (CH) | 2022-04-21 | — | — | US | disclosed |
| WO-2021261429-A1 | CURABLE RESIN COMPOSITION, CURED FILM, LAMINATE, METHOD FOR PRODUCING CURED FILM, SEMICONDUCTOR DEVICE, AND THERMOSETTING RESIN | 富士フイルム株式会社 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021132578-A1 | CURABLE RESIN COMPOSITION, CURED FILM, LAYERED PRODUCT, METHOD FOR PRODUCING CURED FILM, AND SEMICONDUCTOR DEVICE | 富士フイルム株式会社 | 2021-07-01 | — | — | WO | disclosed |
| EP-0689507-A1 | INK RIBBONS CONTAINING COMPOUNDS ABSORBING IN THE IR REGION | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-03 | — | — | EP | disclosed |
| EP-0666474-A1 | Use of infrared absorbing and fluorescent compositions for flaw detection | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-09 | — | — | EP | disclosed |
| EP-0656929-A1 | USE OF COMPOUNDS WHICH ABSORB AND/OR FLUORESCE IN THE I/R RANGE AS MARKERS FOR LIQUIDS. | BASF AG (DE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0645259-A1 | Thermal transfer of infrared dye-stuffs | BASF Aktiengesellschaft (DE) | 1995-03-29 | — | — | EP | disclosed |
| EP-0632108-A1 | Pigment preparations with anthraquinone derivatives as dispersing agents | BASF Aktiengesellschaft (DE) | 1995-01-04 | — | — | EP | disclosed |
| EP-0628607-A2 | Naphthalocyanine | BASF Aktiengesellschaft (DE) | 1994-12-14 | — | — | EP | disclosed |
| WO-1994021471-A1 | INK RIBBONS CONTAINING COMPOUNDS ABSORBING IN THE IR REGION | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
| WO-1994002570-A1 | USE OF COMPOUNDS WHICH ABSORB AND/OR FLUORESCE IN THE I/R RANGE AS MARKERS FOR LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-03 | — | — | WO | disclosed |
| US-5282894-A | Use of a liquid containing IR dyes as printing ink | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-01 | — | — | US | disclosed |
| EP-0553614-A1 | Use of infrared dyes containing liquid as a printing ink | BASF Aktiengesellschaft (DE) | 1993-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167117-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | TLR7, TLR1, TLR9 | CA2 2199/4885CYP3A4 1328/4885TSHR 590/4885 |
| US-20220119394-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST | TLR7, TLR1, TLR3 | CA2 2967/4885CYP3A4 2042/4885TSHR 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.